Recent performance and what it might mean for investors

Without a single clear news event driving headlines, Palomar Holdings (PLMR) has been drawing attention for its recent trading pattern, combining a slight gain over the past month with weaker year to date and 1 year returns.

The stock closed at US$120.38, with the share price showing a month return of 0.7% but a decline of 8.7% year to date and a 16.4% decline over the past 12 months. Over a 3 year period, however, the total return is very large at about 14x, and over 5 years it stands at 8.1x. This provides a longer term context for the current pullback.

For an insurance name focused on US property and casualty products, that mix of strong multi year total return and more recent softness raises natural questions about how the current price compares with the company’s fundamentals and what kind of risk profile you are comfortable holding.

At a share price of US$120.38, Palomar’s 1 day share price return of a 2.9% decline and 7 day share price return of a 6.5% decline sit against a three year total shareholder return of about 145%. This combination suggests long term momentum, while shorter term sentiment appears to be cooling as investors recheck how current expectations line up with the underlying insurance business.

If this kind of recent pullback has you reviewing your portfolio, it can be a useful moment to widen the lens and see what else fits your criteria, including 18 top founder-led companies

So with Palomar trading at US$120.38, recent increases in revenue and net income, and a share price that sits below some analyst targets, is the current valuation leaving upside on the table or already reflecting future growth?

Most Popular Narrative: 25.1% Undervalued

Against the last close of US$120.38, the most followed narrative suggests a fair value of about US$160.67, using a discount rate of 6.978% to interpret Palomar’s future earnings power.

Ongoing investment in proprietary technology, data analytics, and advanced underwriting disciplines is improving risk assessment and pricing accuracy, already reflected in strong combined ratios and low loss ratios, which should continue to enhance underwriting profitability and expand net margins over time.

Curious what kind of revenue growth, margin profile, and future earnings multiple are baked into that valuation gap? The full narrative spells out the assumptions in detail.

Result: Fair Value of $160.67 (UNDERVALUED)

However, this narrative could be knocked off course if catastrophe exposed lines see heavier than expected losses or if reinsurance terms tighten and squeeze margins.

Another way to look at valuation

The narrative and DCF work suggest Palomar looks undervalued, but the simple P/E comparison tells a tighter story. At 16.2x earnings, the stock trades well above peers at 6.7x and the US Insurance industry at 11.7x, and also sits above its own 14.1x fair ratio. This points to valuation risk if sentiment cools.

That kind of premium often reflects confidence in earnings quality and growth, but it also raises a question for you as an investor: are you comfortable paying well ahead of peers on the view that Palomar will keep justifying that gap over time?

Next Steps

Given this mix of optimism and caution around Palomar, it can be helpful to review the underlying data promptly and form your own perspective using 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Palomar has you thinking harder about quality and price, do not stop here. Broaden your watchlist now so you do not miss the next opportunity.

• Spot potential bargains early by scanning 51 high quality undervalued stocks that pair solid fundamentals with prices that may not fully reflect their strengths.
• Strengthen your portfolio’s foundation by focusing on companies highlighted in the solid balance sheet and fundamentals stocks screener (44 results) that prioritise resilience and financial discipline.
• Uncover under followed opportunities by working through the screener containing 25 high quality undiscovered gems before they sit on everyone else’s radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.